Literature DB >> 3000963

Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats.

B Haraoui, R L Wilder, J B Allen, M B Sporn, R K Helfgott, C E Brinckerhoff.   

Abstract

We studied the effects of oral administration of the retinoid, 4-hydroxyphenyl retinamide (4-HPR), on group A streptococcal cell wall-induced polyarthritis in the rat, a model characterized initially by exudative inflammation of peripheral joints followed by chronic proliferative/erosive synovitis. Experimental arthritis was induced in female LEW/N rats by i.p. injection of streptococcal cell walls in saline (15 micrograms/g body weight). Depending upon the experiment, continuous daily oral administration of the retinoid was begun either 14 days prior to induction of the disease, at the time of cell wall administration and/or 11 days and 31 days after cell wall injection. Dosage was either 1 or 2 mmol 4-HPR/kg of chow. During the course of the disease, severity of clinical illness was assessed by determination of clinical severity index, by histological or radiologic examination, and by measurement of production in vitro of collagenase and prostaglandin E2 by excised synovial tissue. In rats fed the retinoid prior to cell wall injection, both the acute and the chronic responses were suppressed. In rats given the retinoid at the time of cell wall injection, the acute inflammatory response was only partially suppressed on the diet containing 2 mmol 4-HPR/kg chow, but the chronic disease was impressively inhibited in a dose dependent manner. Similarly, in animals with established disease, the drug was also effective; however, the more advanced the illness, the less effective the drug. Clinical observations were paralleled by the histological, radiographical and biochemical analyses. Treated animals showed far less synovial proliferation and joint destruction, and synovial tissues taken from these rats produced lesser amounts of collagenase and prostaglandin E2. No significant toxicity of the retinoid was noted. We conclude that oral administration of 4-HPR suppresses, in a dose and time dependent manner, both the acute and chronic stages of streptococcal cell wall-induced arthritis in rats without apparent significant toxicity. Our data suggest that studies of the effects of this retinoid on patients with chronic inflammatory synovitis are warranted.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000963     DOI: 10.1016/0192-0561(85)90054-2

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  14 in total

1.  Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.

Authors:  R Lafyatis; E F Remmers; A B Roberts; D E Yocum; M B Sporn; R L Wilder
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 2.  Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

Authors:  D J Schroen; C E Brinckerhoff
Journal:  Gene Expr       Date:  1996

3.  Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable.

Authors:  D E Yocum; R Lafyatis; E F Remmers; H R Schumacher; R L Wilder
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

4.  Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages.

Authors:  W C Hope; B J Patel; C Fiedler-Nagy; B H Wittreich
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

5.  Anti-inflammatory and immuno-modulatory effects of novel retinoid-like 2,4,6,8-nonatetraenoic acids (NTA) in adjuvant-induced arthritis.

Authors:  A C Hanglow; M Rosenberger; A J Lovey; R Nemzek; A F Welton; J W Coffey
Journal:  Agents Actions       Date:  1989-06

6.  Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes.

Authors:  J P Case; R Lafyatis; E F Remmers; G K Kumkumian; R L Wilder
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

7.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Thymus-dependent and -independent regulation of Ia antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-treated LEW and F344 rats.

Authors:  R L Wilder; J B Allen; C Hansen
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis.

Authors:  H Sano; K Engleka; P Mathern; T Hla; L J Crofford; E F Remmers; C L Jelsema; E Goldmuntz; T Maciag; R L Wilder
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats.

Authors:  J P Case; H Sano; R Lafyatis; E F Remmers; G K Kumkumian; R L Wilder
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.